These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26797672)

  • 1. Analytical characteristics of a biomarker-based risk assessment test for acute kidney injury (AKI).
    Uettwiller-Geiger DL; Vijayendran R; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Apr; 455():93-8. PubMed ID: 26797672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?
    Wetz AJ; Richardt EM; Wand S; Kunze N; Schotola H; Quintel M; Bräuer A; Moerer O
    Crit Care; 2015 Jan; 19(1):3. PubMed ID: 25560277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.
    Chindarkar NS; Chawla LS; Straseski JA; Jortani SA; Uettwiller-Geiger D; Orr RR; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Jan; 452():32-7. PubMed ID: 26522657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NephroCheck data compared to serum creatinine in various clinical settings.
    Pajenda S; Ilhan-Mutlu A; Preusser M; Roka S; Druml W; Wagner L
    BMC Nephrol; 2015 Dec; 16():206. PubMed ID: 26651477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
    Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
    PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest of Urinary [TIMP-2] × [IGFBP-7] for Predicting the Occurrence of Acute Kidney Injury After Cardiac Surgery: A Gray Zone Approach.
    Finge T; Bertran S; Roger C; Candela D; Pereira B; Scott C; Muller L; Louart B; Lefrant JY
    Anesth Analg; 2017 Sep; 125(3):762-769. PubMed ID: 28537976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary [TIMP-2] × [IGFBP-7] for predicting acute kidney injury in patients undergoing orthotopic liver transplantation.
    Schiefer J; Lichtenegger P; Berlakovich GA; Plöchl W; Krenn CG; Baron DM; Baron-Stefaniak J; Faybik P
    BMC Nephrol; 2019 Jul; 20(1):269. PubMed ID: 31315590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates.
    Chen J; Sun Y; Wang S; Dai X; Huang H; Bai Z; Li X; Wang J; Li Y
    Pediatr Res; 2020 May; 87(6):1052-1059. PubMed ID: 31791043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.
    Knafl D; Müller M; Pajenda S; Genc Z; Hecking M; Wagner L
    PLoS One; 2017; 12(11):e0188316. PubMed ID: 29145491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study.
    Göcze I; Jauch D; Götz M; Kennedy P; Jung B; Zeman F; Gnewuch C; Graf BM; Gnann W; Banas B; Bein T; Schlitt HJ; Bergler T
    Ann Surg; 2018 Jun; 267(6):1013-1020. PubMed ID: 28857811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction of acute kidney injury by [TIMP-2]•[IGFBP7].
    Kimmel M; Schanz M; Alscher MD
    Drugs Today (Barc); 2017 Jun; 53(6):349-356. PubMed ID: 28799580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
    Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
    Berdugo MA; Kirson NY; Zimmer L; Beyhaghi H; Toback S; Scarpati LM; Stone MN; Dember R; Tseng-Tham J; Wen J; Miller M
    J Med Econ; 2019 Dec; 22(12):1281-1289. PubMed ID: 31234668
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.
    Tyagi A; Luthra A; Kumar M; Das S
    Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.